Agilent, PRM0525033E2, PROTEEMA, 300Å, 4.6 x 250 mm, 3 µm

PROTEEMA, 300Å, 4.6 x 250 mm, 3 µm. GPC/SEC column, molecular weight range 1000 to 1.2x10^6, ships in water

Specifications:
Brand: PROTEEMA
Guard Column: No
Inner Diameter (ID): 4.6 mm
Length: 250 mm
Maximum Temperature: 70 °C
Molecular Weight Lower Limit: 1000 Da
Molecular Weight Upper Limit: 1200000 Da
Particle Size: 3 µm
Particle Type: Individual Pore Size
Pore Size: 300 Å
Pressure Rating: 200 bar
Shipping Solvent: Water
UNSPSC Code: 41115709
pH Range: 2-8

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
Designed for high-performance liquid chromatography, this 300 Angstrom, 4.6 x 250 mm, 3 micron column delivers superior resolution and sensitivity for the analysis of high molecular weight biomolecules, including proteins and peptides. Its large pore size enables efficient separation of challenging samples such as monoclonal antibodies and complex biotherapeutics without compromising peak shape or recovery.

Optimized for reversed-phase separations, this column supports a wide range of research applications within proteomics, biopharmaceutical characterization, and quality control laboratories. The robust particle design ensures consistent performance and longevity, even under demanding analytical workflows.

Ideal for use with Agilent 1100, 1200, and 1260 Infinity LC systems as well as other major HPLC platforms, it integrates seamlessly into existing laboratory setups. The column demonstrates excellent compatibility with mass spectrometry detection, facilitating in-depth structural elucidation and routine purity assessments.

Suitable accessory and solvent offerings from Agilent enhance the ease of deployment for both method development and routine analysis. This solution is particularly beneficial for laboratories focused on protein identification, post-translational modification analysis, and comparability studies in life sciences research and pharmaceutical development.